Literature DB >> 32767188

Oxidative/Nitroxidative Stress and Multiple Sclerosis.

Tobore Onojighofia Tobore1.   

Abstract

Multiple sclerosis (MS) is a multifactorial, central nervous system, immune-mediated disease characterized by inflammation, demyelination, and neurodegeneration. Evidence suggests a steady rise in MS prevalence over the past five decades in the United States and around the world. Even with increased understanding of immunology, the specific etiological trigger of MS remains unknown. Evidence suggests that oxidative/nitroxidative stress is an important contributor to MS etiology, progression, and clinical symptoms. A multifaceted treatment approach aimed at counteracting oxidative/nitroxidative stress including MS disease-modifying medications, Mediterranean style diet, stress-relieving activities, smoking and alcohol cessation, exercise, and peer support programs is the best way to treat the disease.

Entities:  

Keywords:  Antioxidants; Axonal damage; Cognitive and psychiatric disorders; Demyelinating diseases; Gut microbiota; Immune dysfunction; Ketogenic diet; Mediterranean diet; Mitochondrial dysfunction; Multiple sclerosis; Neurodegeneration; Neuroinflammation; Oxidative/nitroxidative stress; Pain; Peer support programs; Sleep disturbance

Year:  2020        PMID: 32767188     DOI: 10.1007/s12031-020-01672-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  67 in total

Review 1.  The cost burden of multiple sclerosis in the United States: a systematic review of the literature.

Authors:  Gabriel Adelman; Stanley G Rane; Kathleen F Villa
Journal:  J Med Econ       Date:  2013-03-07       Impact factor: 2.448

Review 2.  Multiple sclerosis and cognition: synaptic failure and network dysfunction.

Authors:  Massimiliano Di Filippo; Emilio Portaccio; Andrea Mancini; Paolo Calabresi
Journal:  Nat Rev Neurosci       Date:  2018-10       Impact factor: 34.870

Review 3.  Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?

Authors:  Jack Antel; Samson Antel; Zografos Caramanos; Douglas L Arnold; Tanja Kuhlmann
Journal:  Acta Neuropathol       Date:  2012-02-11       Impact factor: 17.088

Review 4.  Diagnosis and management of multiple sclerosis.

Authors:  Peter A Calabresi
Journal:  Am Fam Physician       Date:  2004-11-15       Impact factor: 3.292

5.  Peroxynitrite formation within the central nervous system in active multiple sclerosis.

Authors:  A H Cross; P T Manning; R M Keeling; R E Schmidt; T P Misko
Journal:  J Neuroimmunol       Date:  1998-08-01       Impact factor: 3.478

Review 6.  Vitamin B12, folate, and homocysteine levels and multiple sclerosis: A meta-analysis.

Authors:  Efthimios Dardiotis; Stylianos Arseniou; Maria Sokratous; Zisis Tsouris; Vasileios Siokas; Alexios-Fotios A Mentis; Amalia Michalopoulou; Athina Andravizou; Metaxia Dastamani; Konstantinos Paterakis; Dimitrios Bogdanos; Alexandros Brotis
Journal:  Mult Scler Relat Disord       Date:  2017-08-16       Impact factor: 4.339

7.  Poor sleep in patients with multiple sclerosis.

Authors:  Hanne Marie Bøe Lunde; Tommy F Aae; William Indrevåg; Jan Aarseth; Bjørn Bjorvatn; Kjell-Morten Myhr; Lars Bø
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

8.  Pilot study of a ketogenic diet in relapsing-remitting MS.

Authors:  J Nicholas Brenton; Brenda Banwell; A G Christina Bergqvist; Diana Lehner-Gulotta; Lauren Gampper; Emily Leytham; Rachael Coleman; Myla D Goldman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-04-12

9.  Melatonin acts as antioxidant and improves sleep in MS patients.

Authors:  Monika Adamczyk-Sowa; Krystyna Pierzchala; Pawel Sowa; Sebastian Mucha; Izabela Sadowska-Bartosz; Jowita Adamczyk; Marcin Hartel
Journal:  Neurochem Res       Date:  2014-06-30       Impact factor: 3.996

10.  Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.

Authors:  Jun Chen; Nicholas Chia; Krishna R Kalari; Janet Z Yao; Martina Novotna; M Mateo Paz Soldan; David H Luckey; Eric V Marietta; Patricio R Jeraldo; Xianfeng Chen; Brian G Weinshenker; Moses Rodriguez; Orhun H Kantarci; Heidi Nelson; Joseph A Murray; Ashutosh K Mangalam
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more
  8 in total

Review 1.  Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis.

Authors:  Hina Khan; Fareeha Khalid Ghori; Uzma Ghani; Aneela Javed; Saadia Zahid
Journal:  Mol Biol Rep       Date:  2022-02-18       Impact factor: 2.742

Review 2.  Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis.

Authors:  Margo I Jansen; Sarah Thomas Broome; Alessandro Castorina
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Explaining stress coping behaviors in patients with multiple sclerosis based on the PRECEDE model: a qualitative directed content analysis.

Authors:  Atefeh Homayuni; Zahra Hosseini; Sedigheh Abedini
Journal:  BMC Psychiatry       Date:  2021-12-20       Impact factor: 3.630

4.  Dapsone reduced cuprizone-induced demyelination via targeting Nrf2 and IKB in C57BL/6 mice.

Authors:  Ahmad Reza Dehpour; Ehsan Khaledi; Tayebeh Noori; Ahmad Mohammadi-Farani; Ladan Delphi; Antoni Sureda; Eduardo Sobarzo-Sanchez; Samira Shirooie
Journal:  Iran J Basic Med Sci       Date:  2022-06       Impact factor: 2.532

Review 5.  Neurodegeneration in Multiple Sclerosis: The Role of Nrf2-Dependent Pathways.

Authors:  Paloma P Maldonado; Coram Guevara; Margrethe A Olesen; Juan Andres Orellana; Rodrigo A Quintanilla; Fernando C Ortiz
Journal:  Antioxidants (Basel)       Date:  2022-06-10

6.  Expression of antioxidant enzymes in lesions of multiple sclerosis and its models.

Authors:  Dorsa Moezzi; Yifei Dong; Rajiv W Jain; Brian M Lozinski; Samira Ghorbani; Charlotte D'Mello; V Wee Yong
Journal:  Sci Rep       Date:  2022-07-26       Impact factor: 4.996

Review 7.  Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis.

Authors:  Zheng Zha; Sisi Liu; Yijiang Liu; Chen Li; Lei Wang
Journal:  Antioxidants (Basel)       Date:  2022-07-29

8.  Oligodendrocyte Physiology and Pathology Function.

Authors:  Markus Kipp
Journal:  Cells       Date:  2020-09-11       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.